Form 4: Core Laboratories Inc. Executive Reports Stock Transactions

Mark Damian Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., reports transactions involving common stock and restricted shares on May 1, 2025.

Summary

• On May 1, 2025, Mark Damian Tattoli, SVP, Gen Counsel & Secretary of Core Laboratories Inc., reported transactions involving the company's stock.
• These transactions included the disposition of 99 shares of common stock at a price of $11.68, the acquisition of 250 shares of common stock, and the disposition of 79 shares of common stock at a price of $11.68.
• Additionally, Tattoli acquired 200 shares of common stock.
• Following these transactions, Tattoli directly owns 16,071.621 shares of common stock and indirectly owns 1,694.842 shares through a 401(k) plan and 20 shares in a custodial account.
• Tattoli also reported transactions involving restricted shares, with 250 and 200 shares vesting on May 1, 2025, resulting in holdings of 2,400 and 2,650 restricted shares respectively.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It is a standard practice for publicly traded companies.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly altering the ownership structure.

Key Dates

Keywords

Form 4, beneficial ownership, stock transactions, restricted shares, Core Laboratories Inc., Tattoli, CLB